Relation of antibiotic use to risk of myocardial infarction in the general population

American Journal of Cardiology

Volumn 89, Issue 1, 2002, Pages 18-21

  Luchsinger, José A ^a,e   Pablos Méndez, Ariel ^a,b   Knirsch, Charles ^a,d   Rabinowitz, Daniel ^c   Shea, Steven ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d PFIZER INC   (United States)

^e Division of General Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

AGE; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ACTIVITY; DRUG USE; FEMALE; HEALTH CARE; HEALTH HAZARD; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DATABASES, FACTUAL; FEMALE; HUMANS; INSURANCE; MACROLIDES; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; PENICILLINS; PNEUMONIA, BACTERIAL; PROPORTIONAL HAZARDS MODELS; QUINOLONES; RETROSPECTIVE STUDIES; RISK FACTORS; TETRACYCLINES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES;

EID: 0036145623     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02156-7     Document Type: Article

References (30)

1. Infections and atherosclerosis: New clues from an old hypothesis?
2. Chronic Chlamydia pneumoniae infection as a risk factor for coronary artery disease in the Helsinki heart study
3. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
4. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
5. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues
6. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
7. Prospective study of Chlamydia pneumoniae IgG seropositivity and risk of future myocardial infarction
8. Chlamydia pneumoniae infection and incident coronary heart disease
9. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk of cardiovascular disease in women
10. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae
11. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae
12. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
13. Randomized trial of roxithromycin in non-Q wave coronary syndromes: Roxis pilot study
14. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in coronary artery disease: Elimination of Myocardial infection (ACADEMIC) study
15. Secondary prevention antibiotic treatment trials for coronary artery disease
16. Antibiotics and risk of subsequent first-time acute myocardial infarction
17. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline
18. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
19. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity
20. Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease
21. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
22. Chlamydia infections and heart disease linked through antigenic mimicry
23. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression
24. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae
25. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the academic study
26. Pneumonia due to chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment
27. The epidemiology and significance of Chlamydia pneumoniae
28. An assessment of the validity of ICD-9 code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi heart project